Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) insider Campbell Rogers sold 16,918 shares of the company's stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $24.67, for a total transaction of $417,367.06. Following the completion of the transaction, the insider directly owned 83,511 shares in the company, valued at $2,060,216.37. The trade was a 16.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Campbell Rogers also recently made the following trade(s):
- On Thursday, October 22nd, Campbell Rogers sold 12,157 shares of Heartflow stock. The shares were sold at an average price of $55.01, for a total transaction of $668,756.57.
- On Friday, September 18th, Campbell Rogers sold 12,156 shares of Heartflow stock. The shares were sold at an average price of $50.15, for a total transaction of $609,623.40.
- On Tuesday, November 17th, Campbell Rogers sold 12,157 shares of Heartflow stock. The stock was sold at an average price of $46.39, for a total transaction of $563,963.23.
- On Tuesday, November 17th, Campbell Rogers sold 24,188 shares of Heartflow stock. The stock was sold at an average price of $46.39, for a total transaction of $1,122,081.32.
- On Thursday, October 22nd, Campbell Rogers sold 23,933 shares of Heartflow stock. The shares were sold at an average price of $55.01, for a total transaction of $1,316,554.33.
- On Friday, September 18th, Campbell Rogers sold 19,682 shares of Heartflow stock. The shares were sold at an average price of $50.15, for a total value of $987,052.30.
Heartflow Stock Down 2.7%
NASDAQ:HTFL traded down $1.26 during trading hours on Thursday, reaching $44.63. 1,279,655 shares of the stock were exchanged, compared to its average volume of 1,615,683. Heartflow, Inc. has a twelve month low of $20.13 and a twelve month high of $60.65. The business has a 50-day moving average of $51.84 and a two-hundred day moving average of $35.47. The company has a market capitalization of $3.92 billion, a price-to-earnings ratio of -48.51 and a beta of 2.50.
Heartflow (NASDAQ:HTFL - Get Free Report) last posted its quarterly earnings data on Thursday, November 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.18) by $0.15. Heartflow had a negative return on equity of 20.53% and a negative net margin of 33.11%. The firm had revenue of $72.86 million for the quarter. During the same quarter in the prior year, the firm posted ($0.27) EPS. On average, research analysts forecast that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.
Institutional Investors Weigh In On Heartflow
Several institutional investors have recently added to or reduced their stakes in HTFL. GAMMA Investing LLC lifted its holdings in shares of Heartflow by 75.1% in the 3rd quarter. GAMMA Investing LLC now owns 641 shares of the company's stock valued at $32,000 after purchasing an additional 275 shares during the last quarter. Allworth Financial LP grew its position in Heartflow by 56.5% in the 3rd quarter. Allworth Financial LP now owns 828 shares of the company's stock valued at $41,000 after buying an additional 299 shares during the last quarter. Entropy Technologies LP increased its stake in Heartflow by 7.1% in the 3rd quarter. Entropy Technologies LP now owns 10,156 shares of the company's stock valued at $505,000 after buying an additional 672 shares during the period. IFP Advisors Inc lifted its stake in shares of Heartflow by 844.7% in the 3rd quarter. IFP Advisors Inc now owns 803 shares of the company's stock worth $40,000 after acquiring an additional 718 shares during the period. Finally, State Board of Administration of Florida Retirement System boosted its holdings in shares of Heartflow by 7.5% in the third quarter. State Board of Administration of Florida Retirement System now owns 10,671 shares of the company's stock valued at $531,000 after acquiring an additional 740 shares in the last quarter.
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on HTFL shares. UBS Group assumed coverage on shares of Heartflow in a report on Wednesday, September 9th. They issued a "neutral" rating and a $55.00 price objective for the company. Wall Street Zen raised Heartflow from a "hold" rating to a "buy" rating in a research report on Sunday. Piper Sandler reiterated an "overweight" rating and issued a $64.00 price objective (up from $45.00) on shares of Heartflow in a research note on Tuesday, October 20th. Benchmark reissued a "buy" rating on shares of Heartflow in a research report on Friday, August 14th. Finally, Robert W. Baird upped their target price on shares of Heartflow from $56.00 to $68.00 and gave the stock an "outperform" rating in a research note on Friday, November 13th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $60.12.
Get Our Latest Stock Analysis on HTFL
Heartflow Company Profile
(
Get Free Report)
HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient's coronary arteries and provide information that can support diagnosis and treatment planning. The company's offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Heartflow, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Heartflow wasn't on the list.
While Heartflow currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.